ABBV Cumulative FCF
The running total of free cash flow across the series, showing cumulative cash generated to date.
Cumulative FCF
Latest: $184.69B (2026Q2)
| Period | Value |
|---|---|
| 2020Q3 | $69.48B |
| 2020Q4 | $74.06B |
| 2021Q1 | $78.75B |
| 2021Q2 | $83.44B |
| 2021Q3 | $91.16B |
| 2021Q4 | $96.05B |
| 2022Q1 | $100.80B |
| 2022Q2 | $105.66B |
| 2022Q3 | $113.08B |
| 2022Q4 | $120.30B |
| 2023Q1 | $124.32B |
| 2023Q2 | $130.46B |
| 2023Q3 | $137.81B |
| 2023Q4 | $142.36B |
| 2024Q1 | $146.21B |
| 2024Q2 | $148.24B |
| 2024Q3 | $153.44B |
| 2024Q4 | $160.19B |
| 2025Q1 | $161.59B |
| 2025Q2 | $166.48B |
| 2025Q3 | $173.12B |
| 2025Q4 | $178.01B |
| 2026Q1 | $181.57B |
| 2026Q2 | $184.69B |
Other ABBV Charts
More quarter-by-quarter fundamentals for AbbVie Inc.
1 / 10
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Shares Outstanding
Total Assets
Total Debt
Rule of 40
Healthcare Comparison
1 / 3
Cumulative FCF
Cumulative FCF
Cumulative FCF
Latest Cumulative FCF: $184.69B (2026Q2); +10.9% YoY; +47.2% CAGR since 2013Q1 (13.25y).
Across the 54 quarters from 2013Q1 to 2026Q2, Cumulative FCF ranged from $1.10B in 2013Q1 to $184.69B in 2026Q2.
Chart and table show the latest 24 of 54 quarters.